BASKING RIDGE, N.J., April 11, 2007 (PRIME NEWSWIRE) -- Millennium Biotechnologies, Inc. a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTCBB:MBTG) announces today that it has signed a letter of intent with New Marketlink Pharmaceutical Corp., a Philippine pharmaceutical company for the distribution and marketing of its Resurgex(r) product line for the oncology market.
